Avalon Trust’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-352
Closed -$114K 503
2025
Q3
$114K Buy
352
+2
+0.6% +$622 0.01% 215
2025
Q2
$136K Hold
350
0.01% 167
2025
Q1
$152K Hold
350
0.01% 152
2024
Q4
$129K Hold
350
0.01% 151
2024
Q3
$182K Sell
350
-50
-13% -$26.7K 0.01% 126
2024
Q2
$217K Hold
400
0.02% 123
2024
Q1
$207K Hold
400
0.02% 129
2023
Q4
$189K Hold
400
0.02% 125
2023
Q3
$174K Hold
400
0.02% 124
2023
Q2
$178K Hold
400
0.02% 130
2023
Q1
$184K Buy
+400
New +$190K 0.02% 123

Other funds holding ELV

Avalon Trust's ELV Position: Q4 2025 in Review

Avalon Trust sold out of Elevance Health (ELV) in Q4 2025, closing a stake of 352 shares — an estimated $114K sold.

Avalon Trust first reported a position in ELV in Q1 2023 and held it in 11 quarters. The position peaked at $217K in Q2 2024. 1,555 funds tracked by Wall St. Rank hold ELV as of Q4 2025.

  • Avalon Trust reported no remaining Elevance Health position as of Q4 2025 after selling out during the quarter.
  • Avalon Trust sold 352 Elevance Health shares in Q4 2025, an estimated $114K.
  • Avalon Trust first reported a position in Elevance Health in Q1 2023 and held it in 11 quarters.
  • Avalon Trust's Elevance Health position peaked at $217K in Q2 2024.
  • 1,555 funds tracked by Wall St. Rank held Elevance Health as of Q4 2025.

Based on Avalon Trust's 13F filing for Q4 2025, filed 9 Feb 2026.